Sage Journals: Discover world-class research

Open access

Review article

First published 2024

Role of SGLT-2 Inhibitors in Ultrafiltration Failure in Peritoneal Dialysis: A Narrative Review

Magdalena Riedl Khursigara, Ping Liu, Reetinder Kaur [...]

Canadian Journal of Kidney Health and Disease

Free access

Research article

First published 2014-7

The Role of Self-Monitoring of Blood Glucose in Patients Treated With SGLT-2 Inhibitors

Oliver Schnell, Hasan Alawi, Tadej Battelino [...]

Journal of Diabetes Science and Technology

Retricted access

Review article

First published 2017

SGLT-2 Inhibitors: Is There a Role in Type 1 Diabetes Mellitus Management?

Nabila Ahmed-Sarwar, Angela K. Nagel, Samantha Leistman [...]

Annals of Pharmacotherapy

Open access

Case report

First published 2022

The Use of SGLT-2 Inhibitors Coupled With a Strict Low-Carbohydrate Diet: A Set-Up for Inducing Severe Diabetic Ketoacidosis

Helpees Guirguis, Shiela Beroukhim Afrahimi, Charles Pham

Clinical Medicine Insights: Case Reports

Retricted access

Case report

First published 2020-1

Postoperative Euglycemic Diabetic Ketoacidosis and Encephalopathy Related to SGLT-2 Inhibitors: A Case Report and Discussion of Diabetes Treatment and “Sweet Pee Encephalopathy” in Perioperative Hospital Management

Christopher Mackintosh, Arti Tewari, Jason Siegel [...]

The Neurohospitalist

Retricted access

Review article

First published 2015-09

The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure

Kayla Riggs, Hiba Ali, Heinrich Taegtmeyer [...]

Metabolic Syndrome and Related Disorders

Open access

Research article

First published 2019

Use of SGLT-2 Inhibitors in Patients With Type 1 Diabetes Mellitus

Lea El Hage, Sangeeta R Kashyap, Pratibha Rao

Journal of Primary Care & Community Health

Retricted access

Research article

First published 2016-02

Diabetes Management and Cardiovascular Risk: Are SGLT-2 Inhibitors the Safest?

Arthur L. M. Swislocki, Ishwarlal Jialal

Metabolic Syndrome and Related Disorders

Open access

Review article

First published 2020

Sodium glucose cotransporter (SGLT)-2 inhibitors alleviate the renal stress responsible for sympathetic activation

Motoaki Sano

Therapeutic Advances in Cardiovascular Disease

Free access

Review article

First published 2019-9

SGLT-2 Inhibitors and GLP-1 Agonists: First-Line Therapy for Diabetes With Established Cardiovascular Disease

Aparna P. Sajja, Amit K. Dey, Avirup Guha [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Search results